Post by Da Admin on Nov 7, 2023 16:43:34 GMT
The price of insulin is a major concern in the US healthcare system. Between 2002 and 2013, the cost of insulin has tripled, and many individuals with diabetes struggle to afford the medication they need to manage their condition. The high cost of insulin is partly due to a lack of competition in the market, as well as the complex and opaque pricing structure of the pharmaceutical industry. This has led to calls for greater regulation and transparency to ensure that all patients have access to affordable and life-saving medication. All lives matter more than insulin revenue.